Navigation Links
Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70
Date:1/30/2013

%9.5

%(5.5)

% Haemonetics Corporation Financial Summary(Unaudited data in thousands, except per share data)Consolidated Statements of Income for Year-to-Date FY13 and FY1212/29/201212/31/2011% Inc/(Dec)As ReportedAs Reportedvs Prior YearNet revenues$

642,048$

541,17418.6

%Gross profit

304,990274,62911.1

%R&D

30,82328,1909.3

%S,G&A

235,438180,22130.6

%Contingent consideration income

—(1,580)(100.0)

%Operating expenses

266,261206,83128.7

%Operating income

38,72967,798(42.9)

%Other income (expense), net

(3,518)370Income before taxes

35,21168,168(48.3)

%Tax expense

8,97219,088(53.0)

%Net income$26,239$49,080(46.5)

%Net income per common share assuming dilution$0.50$0.95(47.4)

%Weighted average number of shares:Basic

51,36450,818Diluted

52,26451,666Profit Margins:Inc/(Dec) vs prior year profit margin %Gross profit

47.5

%50.7

%(3.2)

%R&D

4.8

%5.2

%(0.4)

%S,G&A

36.7

%33.3

%3.4

%Operating income

6.0

%12.5

%(6.5)

%Income before taxes

5.5

%12.6

%(7.1)

%Net income

4.1

%9.1

%(5.0)

% 

 Revenue Analysis for the Third Quarter FY13 and FY12(Unaudited data in thousands)Three Months Ended12/29/201212/31/2011% Inc/(Dec)As ReportedAs Reportedvs Prior YearRevenues by geographyUnited States

$

125,362$

92,1
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
2. Haemonetics Completes Acquisition of Palls Transfusion Medicine Business
3. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
4. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
5. PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
6. Lilly Reports Fourth-Quarter and Full-Year 2012 Results, Revises 2013 EPS Guidance
7. Danaher Reports Record Fourth Quarter 2012 Results
8. Encision Reports 10% Product Revenue Increase in Third Quarter of Fiscal Year 2013 Results
9. Education and Collaboration Key to Continued Progress in Fighting Rogue Online Prescription Drug Sellers, Reports NABP
10. Uroplasty Reports Fiscal Third Quarter 2013 Financial Results
11. Cepheid Reports Fourth Quarter And Full Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015 Roughly three-quarters of ... confident substituting an interchangeable biosimilar for its branded ... same nonproprietary name, according to a survey published ... Journal of Managed Care & Specialty Pharmacy ... percent of pharmacists would feel as confident if ...
(Date:2/27/2015)... Feb. 27, 2015 The role of the ... but one thing hasn,t changed: face-to-face meetings are seen ... with Key Opinion Leaders. Yet at the ... valuable type of interaction, field medical teams within the ... interactions. This is just one of the challenges addressed ...
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015  Pomerantz ... Vitae Pharmaceuticals, Inc. ("Vitae" or the "Company") (NASDAQ: ... Robert S. Willoughby at rswilloughby@pomlaw.com ... whether Vitae and certain of its officers and/or directors ... Exchange Act of 1934.  On February ...
Breaking Medicine Technology:Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2
... and LYNBROOK, N.Y., Aug. 31, 2011 Auxilium Pharmaceuticals, ... company, and BioSpecifics Technologies Corp. (NASDAQ: BSTC ... dismissed all pending litigation between the Companies and announced ... cellulite and human and canine lipoma as well as ...
... 31, 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ... Torley, M.B. Ch. B., M.R.C.P.,  as Executive Vice President ... will report to N. Anthony Coles, M.D., President and ... commercial activities related to Nexavar and the potential launch ...
Cached Medicine Technology:Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 2Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 3Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 4Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 5Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 6Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 7Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 8Onyx Pharmaceuticals Appoints Dr. Helen Torley as Chief Commercial Officer 2Onyx Pharmaceuticals Appoints Dr. Helen Torley as Chief Commercial Officer 3
(Date:3/1/2015)... 01, 2015 “ The Barrel Mill ” ... Report, which takes a look at the latest and coolest ... host of NewsWatch and a technology expert, conducted the review ... flavor to drinks. , According to Home Distillation of Alcohol, ... spirits. Well, there’s a pretty cool product that’ll help anyone ...
(Date:2/28/2015)... 2015 Heart diseases are on the ... of urban adult population and 5 percent of rural ... and 20-30 percent of them require specialized investigation and ... coronary vascular diseases (CVD). , A division of Indian ... research report titled “Indian Coronary Stent Market Forecast to ...
(Date:2/28/2015)... The Classic Denture Center , located ... Throughout all of March patients can receive $25 ... service can help overall mouth health and give ... notice certain symptoms that suggest the denture teeth are ... , 1.    Pain, clicking, and popping in the joints, 2.    Pain ...
(Date:2/28/2015)... Carlsbad, CA (PRWEB) February 28, 2015 ... developed a promising new gene therapy procedure for the ... progressive blindness in patients. Authored by Dr. ... Oxford and published in the Lancet Medical Journal on ... suffering from choroideremia, a rare genetic disorder that mostly ...
(Date:2/28/2015)... February 28, 2015 Dr. Perry ... Coast area residents, recently announced a special offer for ... a treatment option for new and established patients at ... with a bright, white smile, Dr. Patel and his ... $299, marked down from the regular price of $450. ...
Breaking Medicine News(10 mins):Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2
... world’s first genetically altered chicken eggs that can be used to ... of the Roslin Institute at Edinburgh, Scotland have claimed ... that can be used to create life saving drugs. ... fraction of what the National Health Service incurs, according to them. ...
... a source of bone for grafting may avoid the complications ... according to a report in the November/December issue //of The ... bone could become the new standard for harvesting bone grafts ... Polley and colleagues of Rush University Medical Center, Chicago. ...
... have announced the discovery of another gene responsible for ... of the disease (occurring in around 90 percent of ... from Boston University, the University of Toronto, and Columbia ... published in Nature Genetics. ,The reasearchers ...
... bigger trial of a vaccine against the most common form ... time for many. // ,The vaccine called Stimuvax was ... to conventional treatment and suggested that the vaccine might be ... the online edition of BBC News. ,The vaccine ...
... by scientists at the Vanderbilt Kennedy Center for Research ... prenatal exposure to cocaine and behavioral //and neurological problems ... the Journal of Neuroscience, Gregg Stanwood, Ph.D., and Pat ... exposure to cocaine in rabbits, which caused a prolonged ...
... Minnesota Medical School, have found that - families whose meals ... unhealthy eating habits, //poor access to healthy foods at home, ... were published in the January 2007 issue of Public Health ... environment of families who ate fast food for dinner more ...
Cached Medicine News:Health News:No Pills Just Omelets 2Health News:New Technique Uses Pubic Bone for Grafting 2Health News:New Gene to Help in Understanding Alzheimer’s Diseas 2Health News:Cocaine During Pregnancy can Cause Behavioral and Neurological Problems in the Child 2Health News:Cocaine During Pregnancy can Cause Behavioral and Neurological Problems in the Child 3Health News:Fast Food Limits Healthy Food Intake, Increases Obesity Risk 2
9 inch double ended with one end black and the other end with 49 holes...
49 pinholes, black...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Long handle occluders are approximately 9 inches long....
Medicine Products: